Published in Infect Immun on June 01, 1992
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest (1994) 1.85
Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4. Infect Immun (1993) 1.04
Chemotaxis to oligopeptides by Pseudomonas aeruginosa. Appl Environ Microbiol (1994) 0.96
Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun (1994) 0.79
Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells. Antimicrob Agents Chemother (1999) 0.78
The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol (1975) 3.50
Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J Immunol Methods (1980) 3.12
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest (1987) 2.93
Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol (1988) 1.99
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. Am Rev Respir Dis (1987) 1.25
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun (1985) 1.14
Mechanisms of neutrophil-mediated killing of endothelial cells. J Leukoc Biol (1990) 1.10
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
The chemotactic peptide receptor. A model for future understanding of chemotactic disorders. Hematol Oncol Clin North Am (1988) 1.01
Laminin promotes the oxidative burst in human neutrophils via increased chemoattractant receptor expression. J Immunol (1989) 0.93
Polymorphonuclear leukocyte- and Pseudomonas aeruginosa-induced damage to a human pulmonary epithelial cell line. J Infect Dis (1990) 0.91
Initial recruitment of neutrophils to alveolar structures in acute lung injury. J Appl Physiol (1985) (1991) 0.90
Relationship between chemical composition and biological function of Pseudomonas aeruginosa lipopolysaccharide: effect on human neutrophil chemotaxis and oxidative burst. J Leukoc Biol (1991) 0.89
Effect of tumor necrosis factor on the generation of chlorinated oxidants by adherent human neutrophils. J Leukoc Biol (1991) 0.89
Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes. J Leukoc Biol (1989) 0.88
Lipopolysaccharide releases a priming substance from platelets that augments the oxidative response of polymorphonuclear neutrophils to chemotactic peptide. J Infect Dis (1988) 0.85
Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils. J Leukoc Biol (1988) 0.81
Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun (1983) 1.14
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun (1985) 1.14
SipA, SopA, SopB, SopD and SopE2 effector proteins of Salmonella enterica serovar Typhimurium are synthesized at late stages of infection in mice. Microbiology (2007) 1.08
Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun (1983) 1.06
Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother (1999) 1.05
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina. Epidemiol Infect (2001) 1.02
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01
The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin Immunol Immunopathol (1994) 0.95
Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. J Microencapsul (1989) 0.95
Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine. Infect Immun (1992) 0.94
Lipopolysaccharide directly affects pancreatic acinar cells: implications on acute pancreatitis pathophysiology. Dig Dis Sci (2000) 0.91
Quantitative determination of bacterial replication in vivo. Infect Immun (1985) 0.91
Comparative usefulness of ribotyping, exotoxin A genotyping, and SalI restriction fragment length polymorphism analysis for Pseudomonas aeruginosa lineage assessment. Diagn Microbiol Infect Dis (1996) 0.87
Pulmonary cell response to bacterial challenge in mutant mice with some hereditary alterations resembling cystic fibrosis. Life Sci (1980) 0.87
Pulmonary nonspecific defense mechanisms in cystic fibrosis. I. Phagocytic capacity of alveolar macrophages and neutrophils. Pediatr Res (1980) 0.87
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis (1985) 0.86
Immunization with temperature-sensitive mutants of Salmonella typhi induces protection in mice. Vaccine (1991) 0.85
Sequences related to Tn1331 associated with multiple antimicrobial resistance in different Salmonella serovars. Int J Antimicrob Agents (1995) 0.84
The emergence of resistance to amikacin in Serratia marcescens isolates from patients with nosocomial infection. Int J Antimicrob Agents (1996) 0.84
Neutrophil erythrotoxicity induced by phorbol myristate acetate: mechanisms involved in neutrophil activation. J Leukoc Biol (1991) 0.84
Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob Agents Chemother (1985) 0.84
Pulmonary clearance of Staphylococcus aureus in mutant mice with some hereditary alterations resembling cystic fibrosis. Pediatr Res (1977) 0.83
Pseudomonas aeruginosa ribotyping: stability and interpretation of ribosomal operon restriction patterns. Diagn Microbiol Infect Dis (1996) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus protects mice from experimental mastitis. FEMS Immunol Med Microbiol (1998) 0.83
Intramammary immunization with live-attenuated Staphylococcus aureus: microbiological and immunological studies in a mouse mastitis model. FEMS Immunol Med Microbiol (1996) 0.83
The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats. Int J Pancreatol (1996) 0.82
Molecular fingerprinting of Staphylococcus aureus isolated from patients with osteomyelitis in Argentina and clonal distribution of the cap5(8) genes and of other selected virulence genes. Eur J Clin Microbiol Infect Dis (2012) 0.82
Multicenter study on spreading of the tet(M) gene in tetracycline-resistant Streptococcus group G and C isolates in Argentina. Antimicrob Agents Chemother (2002) 0.82
Short communication. Role of agar beads in the pathogenicity of Pseudomonas aeruginosa in the rat respiratory tract. Pediatr Res (1984) 0.82
Characterization of a new variant of IS257 that has displaced the capsule genes within bovine isolates of Staphylococcus aureus. Infect Immun (2007) 0.82
Piroxicam treatment protects mice from lethal pulmonary challenge with Pseudomonas aeruginosa. J Infect Dis (1989) 0.82
Temperature-sensitive mutants ofStaphylococcus aureus: Isolation and preliminary characterization. Curr Microbiol (1993) 0.81
Enzyme-linked immunosorbent assay antibody responses to a temperature-sensitive mutant of Pseudomonas aeruginosa. Infect Immun (1985) 0.81
Liposomes as carriers for antibiotics. Targeted Diagn Ther (1990) 0.81
The use of plasmid profile analysis and ribotyping for typing Acinetobacter baumannii isolates. J Hosp Infect (1996) 0.80
Differential growth characteristics and immunogenicity of tight and coasting temperature-sensitive mutants of Pseudomonas aeruginosa. Infect Immun (1987) 0.80
Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns. J Immunol (2001) 0.80
Phagocytosis of Candida albicans by alveolar macrophages from patients with cystic fibrosis. Clin Immunol Immunopathol (1982) 0.80
Replication rate of Pseudomonas aeruginosa in the murine lung. Infect Immun (1985) 0.79
An 8-year study of resistance to amikacin in gram-negative bacilli isolates from patients with nosocomial infection at one hospital in Argentina. J Med Microbiol (1995) 0.79
Oral immunization of mice with temperature-sensitive Pseudomonas aeruginosa enhances pulmonary clearance of the wild-type. Vaccine (1991) 0.78
Specific pulmonary defences against Pseudomonas aeruginosa after local immunization with temperature-sensitive mutants. J Gen Microbiol (1987) 0.78
Interaction between granulocytes and antibodies in the enhancement of lung defenses against Staphylococcus aureus after intranasal immunization of mice with live-attenuated bacteria. FEMS Immunol Med Microbiol (1994) 0.78
A temperature-sensitive DNA adenine methyltransferase mutant of Salmonella typhimurium. Arch Microbiol (1998) 0.78
Modulation of human polymorphonuclear leukocyte chemotaxis and superoxide anion production by Pseudomonas aeruginosa exoproducts, IL-1 beta and piroxicam. FEMS Immunol Med Microbiol (1995) 0.78
First report of qacG, qacH and qacJ genes in Staphylococcus haemolyticus human clinical isolates. J Antimicrob Chemother (2008) 0.78
The effect of liposomal cefoperazone against Pseudomonas aeruginosa in a granulocytopenic mouse model of acute lung infection. Infection (1993) 0.77
Protective capacity of a temperature-sensitive mutant of Salmonella enteritidis after oral and intragastric inoculation in a murine model. Vaccine (1993) 0.77
Genetically stable temperature-sensitive mutants of Salmonella typhi induce protection in mice. Vaccine (1993) 0.77
Pulmonary clearance of Staphylococcus aureus and plasma angiotensin-converting enzyme activity in hydrocarbon pneumonitis. Pediatr Res (1983) 0.77
Salmonella enteritidis temperature-sensitive mutants protect mice against challenge with virulent Salmonella strains of different serotypes. FEMS Immunol Med Microbiol (2000) 0.77
Local and systemic immunity against Streptococcus pneumoniae: humoral responses against a non-capsulated temperature-sensitive mutant. FEMS Microbiol Lett (1993) 0.76
Molecular diversity of live-attenuated prototypic vaccine strains and clinical isolates of Staphylococcus aureus. FEMS Microbiol Lett (2001) 0.76
Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity. Br J Cancer (1992) 0.75
Molecular typing of Acinetobacter baumannii-Acinetobacter calcoaceticus complex isolates from endemic and epidemic nosocomial infections. Epidemiol Infect (1995) 0.75
The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins. Agents Actions (1993) 0.75
Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. Chemotherapy (1996) 0.75
Differential persistence, immunogenicity and protective capacity of temperature-sensitive mutants of Salmonella enteritidis after oral or intragastric administration to mice. FEMS Immunol Med Microbiol (1993) 0.75
Attenuated mutants of Staphylococcus aureus with two temperature-sensitive lesions: isolation and characterization. Microbios (1998) 0.75
Temperature-sensitive vaccine strains of "Salmonella typhi". Ann Sclavo Collana Monogr (1986) 0.75
Serum ciliotoxic activity in mutant mice with some hereditary alterations resembling cystic fibrosis. Pediatr Res (1979) 0.75
Remembering a microbiologist: Alfredo Sordelli (1891-1967). Int Microbiol (2001) 0.75
Development of a plasmid vector for easy selection of strong promoters. Curr Microbiol (2000) 0.75
[Decreased pulmonary clearance of bacteria in mice with cribriform degeneration]. Medicina (B Aires) (1980) 0.75
Pulmonary immunodeficiency. Int Arch Allergy Appl Immunol (1985) 0.75
Fts insertional mutant of Salmonella typhimurium. FEMS Microbiol Lett (1995) 0.75
Defective mononuclear phagocytic function in mice homozygous for the cribriform degeneration autosomic recessive mutation. Immunol Commun (1983) 0.75
Live, attenuated vaccines against Pseudomonas: observations in the experimental animal and the human. Ann Sclavo Collana Monogr (1986) 0.75
Pseudomonas aeruginosa pneumonia. Treatment with nonsteroidal anti-inflammatory agents to prevent lung tissue damage. Antibiot Chemother (1971) (1989) 0.75
[Antitumor concomitant immunity: a possible metastasis control mechanism]. Medicina (B Aires) (1989) 0.75